
Making Sense of Multiple Myeloma Clinical Trials: Actively Recruiting Studies for Myeloma Patients
Navigating a multiple myeloma diagnosis can be overwhelming, and the idea of participating in a clinical trial often brings up common fears about safety, costs, and placebos. Join Dr. Isaac Levy for an empowering, patient-focused webinar designed to demystify the clinical research process. He will separate fact from fiction, explaining exactly how trials work, how patient safety is prioritized, and what eligibility truly means so you can make confident, informed decisions about your care.
In addition to answering your most pressing questions, Dr. Levy will highlight actively enrolling multiple myeloma studies available right now at his center, including the DREAMM-10, DREAMM-20, and Sanofi's SubQSA (subcutaneous isatuximab) trials. Whether you are newly diagnosed, currently in treatment, or exploring new options after a relapse, this session will equip you with the knowledge you need to comfortably discuss clinical trials with your medical team.
Cindy introduces the agenda of the event and featured speaker Isaac Levy, MD
Dr. Levy talks about active clinical trials for myeloma patients
Type your questions in the chat and we will answer them!
Cynthia Cahoon, RN

Isaac Levy, MD